RGLS logo

Regulus Therapeutics (RGLS) Earnings Per Share

Annual EPS

-$1.58
+$0.28+15.05%

31 December 2023

RGLS EPS Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly EPS

-$0.21
-$0.04-23.53%

30 September 2024

RGLS Quarterly EPS Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EPS

-$1.06
+$0.19+15.20%

30 September 2024

RGLS TTM EPS Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RGLS EPS Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+15.1%+47.5%+33.3%
3 y3 years+64.9%+78.8%+63.1%
5 y5 years+97.2%+91.9%+94.3%

RGLS EPS High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+64.9%-23.5%+78.8%at high+67.6%
5 y5 yearsat high+97.2%-23.5%+91.9%at high+94.3%
alltimeall timeat high+100.0%-23.5%+100.0%at high+100.0%

Regulus Therapeutics EPS History

DateAnnualQuarterlyTTM
Sept 2024
-
-$0.21(+23.5%)
-$1.06(-15.2%)
June 2024
-
-$0.17(-41.4%)
-$1.25(-13.8%)
Mar 2024
-
-$0.29(-25.6%)
-$1.45(-8.2%)
Dec 2023
-$1.58(-15.1%)
-$0.39(-2.5%)
-$1.58(-0.6%)
Sept 2023
-
-$0.40(+8.1%)
-$1.59(-5.9%)
June 2023
-
-$0.37(-11.9%)
-$1.69(-7.1%)
Mar 2023
-
-$0.42(+5.0%)
-$1.82(-2.2%)
Dec 2022
-$1.86(-42.6%)
-$0.40(-20.0%)
-$1.86(-13.9%)
Sept 2022
-
-$0.50(0.0%)
-$2.16(-18.5%)
June 2022
-
-$0.50(+8.7%)
-$2.65(-9.6%)
Mar 2022
-
-$0.46(-34.3%)
-$2.93(-10.4%)
Dec 2021
-$3.24(-28.0%)
-$0.70(-29.3%)
-$3.27(+13.9%)
Sept 2021
-
-$0.99(+26.9%)
-$2.87(+25.9%)
June 2021
-
-$0.78(-2.5%)
-$2.28(-40.0%)
Mar 2021
-
-$0.80(+166.7%)
-$3.80(-30.9%)
Dec 2020
-$4.50(-58.3%)
-$0.30(-25.0%)
-$5.50(-26.7%)
Sept 2020
-
-$0.40(-82.6%)
-$7.50(-22.7%)
June 2020
-
-$2.30(-8.0%)
-$9.70(-6.7%)
Mar 2020
-
-$2.50(+8.7%)
-$10.40(-5.5%)
Dec 2019
-$10.80(-80.7%)
-$2.30(-11.5%)
-$11.00(-40.5%)
Sept 2019
-
-$2.60(-13.3%)
-$18.50(-33.2%)
June 2019
-
-$3.00(-3.2%)
-$27.70(-31.8%)
Mar 2019
-
-$3.10(-68.4%)
-$40.60(-27.5%)
Dec 2018
-$55.90(-51.3%)
-$9.80(-16.9%)
-$56.00(-11.1%)
Sept 2018
-
-$11.80(-25.8%)
-$63.00(-12.9%)
June 2018
-
-$15.90(-14.1%)
-$72.30(-31.5%)
Mar 2018
-
-$18.50(+10.1%)
-$105.60(-20.4%)
DateAnnualQuarterlyTTM
Dec 2017
-$114.70(-38.3%)
-$16.80(-20.4%)
-$132.70(-17.8%)
Sept 2017
-
-$21.10(-57.1%)
-$161.50(-12.6%)
June 2017
-
-$49.20(+7.9%)
-$184.80(+0.7%)
Mar 2017
-
-$45.60(0.0%)
-$183.60(-1.3%)
Dec 2016
-$185.90(+43.4%)
-$45.60(+2.7%)
-$186.00(+18.3%)
Sept 2016
-
-$44.40(-7.5%)
-$157.20(+10.1%)
June 2016
-
-$48.00(0.0%)
-$142.80(-0.8%)
Mar 2016
-
-$48.00(+185.7%)
-$144.00(+10.1%)
Dec 2015
-$129.60(-16.3%)
-$16.80(-44.0%)
-$130.80(-23.2%)
Sept 2015
-
-$30.00(-39.0%)
-$170.40(-0.7%)
June 2015
-
-$49.20(+41.4%)
-$171.60(+9.2%)
Mar 2015
-
-$34.80(-38.3%)
-$157.20(-0.8%)
Dec 2014
-$154.80(+163.3%)
-$56.40(+80.8%)
-$158.40(+37.5%)
Sept 2014
-
-$31.20(-10.3%)
-$115.20(+24.7%)
June 2014
-
-$34.80(-3.3%)
-$92.40(+13.2%)
Mar 2014
-
-$36.00(+172.7%)
-$81.60(+17.2%)
Dec 2013
-$58.80(-76.9%)
-$13.20(+57.1%)
-$69.60(-12.4%)
Sept 2013
-
-$8.40(-65.0%)
-$79.43(-96.0%)
June 2013
-
-$24.00(0.0%)
-$1988.64(-39.0%)
Mar 2013
-
-$24.00(+4.2%)
-$3258.24(-32.1%)
Dec 2012
-$254.40(-92.8%)
-$23.03(-98.8%)
-$4801.45(-12.0%)
Sept 2012
-
-$1917.61(+48.2%)
-$5458.24(+40.2%)
June 2012
-
-$1293.61(-17.5%)
-$3893.20(+49.8%)
Mar 2012
-
-$1567.21(+130.5%)
-$2599.59(+151.8%)
Dec 2011
-$3554.00(-51.1%)
-$679.82(+92.8%)
-$1032.39(+192.8%)
Sept 2011
-
-$352.56
-$352.56
Dec 2010
-$7273.96
-
-

FAQ

  • What is Regulus Therapeutics annual earnings per share?
  • What is the all time high annual EPS for Regulus Therapeutics?
  • What is Regulus Therapeutics annual EPS year-on-year change?
  • What is Regulus Therapeutics quarterly earnings per share?
  • What is the all time high quarterly EPS for Regulus Therapeutics?
  • What is Regulus Therapeutics quarterly EPS year-on-year change?
  • What is Regulus Therapeutics TTM earnings per share?
  • What is the all time high TTM EPS for Regulus Therapeutics?
  • What is Regulus Therapeutics TTM EPS year-on-year change?

What is Regulus Therapeutics annual earnings per share?

The current annual EPS of RGLS is -$1.58

What is the all time high annual EPS for Regulus Therapeutics?

Regulus Therapeutics all-time high annual earnings per share is -$1.58

What is Regulus Therapeutics annual EPS year-on-year change?

Over the past year, RGLS annual earnings per share has changed by +$0.28 (+15.05%)

What is Regulus Therapeutics quarterly earnings per share?

The current quarterly EPS of RGLS is -$0.21

What is the all time high quarterly EPS for Regulus Therapeutics?

Regulus Therapeutics all-time high quarterly earnings per share is -$0.17

What is Regulus Therapeutics quarterly EPS year-on-year change?

Over the past year, RGLS quarterly earnings per share has changed by +$0.19 (+47.50%)

What is Regulus Therapeutics TTM earnings per share?

The current TTM EPS of RGLS is -$1.06

What is the all time high TTM EPS for Regulus Therapeutics?

Regulus Therapeutics all-time high TTM earnings per share is -$1.06

What is Regulus Therapeutics TTM EPS year-on-year change?

Over the past year, RGLS TTM earnings per share has changed by +$0.53 (+33.33%)